bioMérieux

bioMérieux is a French in vitro diagnostics company founded in 1963 in Marcy-l'Étoile near Lyon, France, that develops, manufactures, and markets diagnostic solutions for clinical microbiology, industrial microbiological quality control, and food safety testing. The company's VITEK 2 automated microbial identification and antimicrobial susceptibility testing system is the standard platform in clinical microbiology laboratories worldwide, using colorimetric biochemical card assays to identify bacterial and yeast isolates from clinical specimens and report minimum inhibitory concentration (MIC) values for antibiotic therapy guidance. For research in antimicrobial resistance and infectious disease, bioMérieux's VITEK MS MALDI-TOF mass spectrometry system enables rapid identification of microorganisms at the species level from colonies within minutes, far faster than biochemical methods. The FILM ARRAY multiplex PCR system performs syndromic testing of respiratory pathogens, gastrointestinal pathogens, blood culture pathogens, and meningitis/encephalitis panels from a single sealed pouch, and its application in hospital outbreak investigation and clinical research has been transformative. bioMérieux's BioFire Defense division develops pathogen detection systems for biodefense applications in government research labs. Their TEMPO automated MPN (most probable number) enumeration systems and NucliSENS NASBA (nucleic acid sequence-based amplification) technologies serve food safety and environmental monitoring researchers. The company's informatics platforms for laboratory automation and infection control surveillance data analysis support translational infectious disease research programs.